CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI – Trademark Portfolio

Entity Type: 99

CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include XUX and CATTELAN. The owner is based in CHONGQING.

JIULONGPOQUXINGYANLU

CHONGQING 400050 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

XUX
XUX
Registered 2020
CATTELAN
CATTELAN
Registered 2020

Trademark Classifications

CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI have?

CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI file in?

CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI's most well-known trademarks?

CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI's registered trademark portfolio includes well-known marks such as XUX and CATTELAN. These are among 2 currently registered trademarks in the portfolio.

What is CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI's trademark registration success rate?

CHONGQINGCHENGHUIDIANZISHANGWUYOUXIANGONGSI has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.